DoP amends DPCO 2013 to ease compliance, clarify overcharging liability
The Department of Pharmaceuticals (DoP) has notified the Drugs (Prices Control) Amendment Order, 2026, introducing a series of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DoP
Kinny Singh appointed Deputy Secretary in Department of Pharmaceuticals
IAS officer Kinny Singh has been appointed as Deputy Secretary in the Department of Pharmaceuticals under the Central Staffing…
DoP eases compliance under UCPMP 2024
The Department of Pharmaceuticals (DoP) has announced key amendments to the Uniform Code for Pharmaceutical Marketing Practices…
DOP amends PTUAS, expands eligibility criteria to include MSMEs
Offers flexible financing options, and focuses on reimbursement subsidies from 10-20 per cent to MSMEs
Parliamentary panel for framing price control regime for COVID medicines medical devices
The panel also recommended exemption of basic customs duty and GST on medicines and medical devices for fighting COVID-19
Deadline for proposals under PLI scheme for bulk drugs extended till March-end
The DoP had issued notice on 27th January inviting applications for vacant slots (10 APIs) under PLI scheme for bulk drug with the…
Government earmarks Rs 500 crores for scheme to support pharma clusters and MSMEs
The objectives of the scheme are to strengthen the existing infrastructure facilities to make India a global leader in the pharma…
Centre to mandatorily revise ceiling prices of drugs every five years
The order is with regard to the Indian Drugs Manufacturers Association's (IDMA) views on notification No. S.O. 3249 (E), dated…
DoP takes measures to mandatorily revise ceiling prices of drugs every five years
Amends Para 18(i) of DPCO 2013 as per a notification issued on August 12, 2021
DoP amends Drugs (Prices Control) Order, 2013
In the amendment, DoP provided the proforma for a price list for medical devices, which needs to be submitted